X0206 3 2015-06-10 0 0001636050 Axovant Sciences Ltd. AXON 0001543663 Cvijic Christine Mikail C/O AXOVANT SCIENCES, INC., 1441 BROADWAY, 3RD FLOOR NEW YORK NY 10018 0 1 0 0 Chief Admin Officer and GC Common Shares 0 D Employee Stock Option (Right to Buy) 0.90 2025-03-17 Common Shares 937500 D This option vests over a period of four years, with one quarter of the common shares underlying the option vesting on March 18, 2016 and the remainder vesting in twelve equal quarterly installments thereafter. The option allows for early exercise, subject to the Issuer's repurchase option with respect to any unvested common shares. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan. Exhibit List - Exhibit 24 - Power of Attorney /s/Alison Haggerty, Attorney-in-Fact 2015-06-10